Overview Dividends

(MKSI) MKS Instruments - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US55306N1046

Pressure Control, Flow Control, Laser Systems, Plating, Photonics

Semiconductor Materials & Equipment
Market Cap in USD: 10,975m

IPO / Inception: 1999-03-26
Return 12m vs S&P 500: 33.3%

EPS (Earnings per Share)

EPS CAGR: -11.25%
EPS Trend: -23.1%

Last SUE: 0.82
Qual. Beats: 0

Revenue

Rev. CAGR: 7.10%
Rev. Trend: 52.9%

Last SUE: 1.15
Qual. Beats: 2

Dividends

Dividend Yield	0.54%
Yield on Cost 5y	0.60%
Yield CAGR 5y	2.41%
Payout Consistency	99.0%
Payout Ratio	11.6%

Risk via 5d forecast
Volatility	48.7%
Value at Risk 5%th	76.5%
Relative Tail Risk	-4.54%

Reward TTM
Sharpe Ratio	0.93
Alpha	19.20
CAGR/Max DD	0.44

Character TTM
Hurst Exponent	0.360
Beta	2.449
Beta Downside	2.756

Drawdowns 3y
Max DD	59.11%
Mean DD	18.92%
Median DD	19.56%

Description: MKSI MKS Instruments November 05, 2025

MKS Inc. (NASDAQ:MKSI) delivers core technology components for semiconductor manufacturing, electronics packaging, and specialty industrial markets across the United States, China, South Korea, Japan, Taiwan, Singapore, and other regions. The firm operates through three divisions: Vacuum Solutions (VSD) – offering pressure, flow, gas delivery, and sensing technologies; Photonics Solutions (PSD) – providing lasers, beam profiling, precision motion, and optical components for PCB and package processing; and Material Solutions (MSD) – manufacturing advanced surface-modification, plating, and finishing products for high-technology applications.

In FY 2024 the company reported revenue of approximately $1.23 billion, a 9 % year-over-year increase driven largely by higher demand for advanced packaging equipment and growth in the Chinese semiconductor fab market. Operating margin expanded to 15 % as the firm leveraged its VSD and PSD product mix to capture a larger share of the $80 billion global semiconductor equipment spend, which is projected to grow at a 6 % CAGR through 2028. Capital expenditures rose to $115 million, reflecting continued investment in R&D for next-generation laser-based processing and vacuum-system automation, key enablers of the industry’s shift toward heterogeneous integration and chiplet architectures.

For a deeper quantitative assessment, you may find the analytics on ValueRay useful.

Piotroski VR‑10 (Strict, 0-10) 5.0

Net Income (279.0m TTM) > 0 and > 6% of Revenue (6% = 229.9m TTM)

FCFTA 0.06 (>2.0%) and ΔFCFTA 1.62pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 43.07% (prev 53.26%; Δ -10.19pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.08 (>3.0%) and CFO 679.0m > Net Income 279.0m (YES >=105%, WARN >=100%)

Net Debt (3.89b) to EBITDA (878.0m) ratio: 4.43 <= 3.0 (WARN <= 3.5)

Current Ratio 2.86 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (67.6m) change vs 12m ago 0.0% (target <= -2.0% for YES)

Gross Margin 46.96% (prev 47.33%; Δ -0.37pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 43.04% (prev 39.27%; Δ 3.78pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 2.35 (EBITDA TTM 878.0m / Interest Expense TTM 227.0m) >= 6 (WARN >= 3)

Altman Z'' 1.95

(A) 0.19 = (Total Current Assets 2.54b - Total Current Liabilities 886.0m) / Total Assets 8.78b

(B) 0.07 = Retained Earnings (Balance) 618.0m / Total Assets 8.78b

(D) 0.08 = Book Value of Equity 510.0m / Total Liabilities 6.18b

Total Rating: 1.95 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 52.52

1. Piotroski 5.0pt

2. FCF Yield 3.57%

3. FCF Margin 13.83%

4. Debt/Equity 1.76

5. Debt/Ebitda 4.43

6. ROIC - WACC (= -4.08)%

7. RoE 11.35%

8. Rev. Trend 52.94%

9. EPS Trend -23.12%

What is the price of MKSI shares?

As of December 28, 2025, the stock is trading at USD 164.19 with a total of 285,211 shares traded.
Over the past week, the price has changed by +2.90%, over one month by +8.01%, over three months by +35.00% and over the past year by +54.87%.

Is MKSI a buy, sell or hold?

MKS Instruments has received a consensus analysts rating of 4.50. Therefore, it is recommended to buy MKSI.

Strong Buy: 7
Buy: 4
Hold: 1
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the MKSI price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	180.9	10.2%
Analysts Target Price	180.9	10.2%
ValueRay Target Price	179.1	9.1%

MKSI Fundamental Data Overview December 27, 2025

Market Cap USD = 10.98b (10.98b USD * 1.0 USD.USD)
P/E Trailing = 39.6602
P/E Forward = 9.901
P/S = 2.8642
P/B = 4.2213
P/EG = 0.61
Beta = 1.929
Revenue TTM = 3.83b USD
EBIT TTM = 534.0m USD
EBITDA TTM = 878.0m USD
Long Term Debt = 4.25b USD (from longTermDebt, last quarter)
Short Term Debt = 82.0m USD (from shortTermDebt, last quarter)
Debt = 4.58b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.89b USD (from netDebt column, last quarter)
Enterprise Value = 14.86b USD (10.98b + Debt 4.58b - CCE 697.0m)
Interest Coverage Ratio = 2.35 (Ebit TTM 534.0m / Interest Expense TTM 227.0m)
FCF Yield = 3.57% (FCF TTM 530.0m / Enterprise Value 14.86b)
FCF Margin = 13.83% (FCF TTM 530.0m / Revenue TTM 3.83b)
Net Margin = 7.28% (Net Income TTM 279.0m / Revenue TTM 3.83b)
Gross Margin = 46.96% ((Revenue TTM 3.83b - Cost of Revenue TTM 2.03b) / Revenue TTM)
Gross Margin QoQ = 46.66% (prev 46.56%)
Tobins Q-Ratio = 1.69 (Enterprise Value 14.86b / Total Assets 8.78b)
Interest Expense / Debt = 1.16% (Interest Expense 53.0m / Debt 4.58b)
Taxrate = 11.90% (10.0m / 84.0m)
NOPAT = 470.4m (EBIT 534.0m * (1 - 11.90%))
Current Ratio = 2.86 (Total Current Assets 2.54b / Total Current Liabilities 886.0m)
Debt / Equity = 1.76 (Debt 4.58b / totalStockholderEquity, last quarter 2.60b)
Debt / EBITDA = 4.43 (Net Debt 3.89b / EBITDA 878.0m)
Debt / FCF = 7.34 (Net Debt 3.89b / FCF TTM 530.0m)
Total Stockholder Equity = 2.46b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.18% (Net Income 279.0m / Total Assets 8.78b)
RoE = 11.35% (Net Income TTM 279.0m / Total Stockholder Equity 2.46b)
RoCE = 7.96% (EBIT 534.0m / Capital Employed (Equity 2.46b + L.T.Debt 4.25b))
RoIC = 6.83% (NOPAT 470.4m / Invested Capital 6.88b)
WACC = 10.91% (E(10.98b)/V(15.56b) * Re(15.04%) + D(4.58b)/V(15.56b) * Rd(1.16%) * (1-Tc(0.12)))
Discount Rate = 15.04% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.37%
[DCF Debug] Terminal Value 56.03% ; FCFE base≈477.6m ; Y1≈460.6m ; Y5≈454.5m
Fair Price DCF = 51.27 (DCF Value 3.44b / Shares Outstanding 67.2m; 5y FCF grow -4.82% → 3.0% )
EPS Correlation: -23.12 | EPS CAGR: -11.25% | SUE: 0.82 | # QB: 0
Revenue Correlation: 52.94 | Revenue CAGR: 7.10% | SUE: 1.15 | # QB: 2
EPS next Quarter (2026-03-31): EPS=1.80 | Chg30d=+0.002 | Revisions Net=+1 | Analysts=13
EPS next Year (2026-12-31): EPS=8.74 | Chg30d=+0.014 | Revisions Net=+1 | Growth EPS=+13.4% | Growth Revenue=+7.5%

Additional Sources for MKSI Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle